Contributors to LVH, aside from hypertension in individuals with CKD, include CKD mineral and bone disorder (e.g., fibroblast growth factor 23, hyperparathyroidism), anemia, uremic toxins, and inflammation [33]. This evidence concerns the gene FGF23 and hyperparathyroidism.